Spinal Cord Stimulation (SCS) Commercialization

This is the breadcrumbs block. Breadcrumb will populate on actual page.

Regulatory Considerations

A listing of regulatory resources for SCS:

Medical device fact sheet

Medical Device Active Licence Listing (MDALL)

e-Learning tool: Understanding How Medical Devices are Regulated in Canada – Premarket Regulation:

    • This tool is recommended for various medical device stakeholders, including manufacturers, importers, distributors, consultants, healthcare groups and academia.

Application forms

    • Separate application forms for each class of device as well as for investigational testing authorization (ITA).

Medical devices in Canada

Praxis SCI Incubate & Accelerate

The Praxis Commercialization team runs SCI Incubate & Accelerate programs. These programs provide targeted consumer and research validation and mentorship, as well as access to our commercialization network.

PathMaker Neurosystems

A member of the 2020 Praxis SCI Accelerate cohort, PathMaker Neurosystems is a clinical-stage neuromodulation company developing breakthrough non-invasive systems for the treatment of patients with serious neurological disorders, including SCI.

Visit their website.


You May Also Be Interested In…

You May Also Be Interested In…

post-image

Spinal Cord Stimulation Platforms for Collaboration in SCI Research and Care

post-image

Spinal Cord Stimulation Consumer Priorities